Morgan Stanley Amgen Inc Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Amgen Inc stock. As of the latest transaction made, Morgan Stanley holds 16,234,121 shares of AMGN stock, worth $4.76 Billion. This represents 0.37% of its overall portfolio holdings.

Number of Shares

16,234,121

Previous 14,559,622 11.5%

Holding current value

$4.76 Billion

Previous $3.79 Billion 33.28%

% of portfolio

0.37%

Previous 0.27%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$258.59 - $327.36 $433 Million - $548 Million	1,674,499 Added 11.5%	16,234,121 $5.06 Billion
Q4 2024 Feb 14, 2025	SELL	$258.78 - $328.31 $34.8 Million - $44.2 Million	-134,600 Reduced 0.92%	14,559,622 $3.79 Billion
Q3 2024 May 14, 2025	BUY	$309.38 - $337.38 $103 Million - $112 Million	331,744 Added 2.31%	14,694,222 $4.73 Billion
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $103 Million - $112 Million	331,744 Added 2.31%	14,694,222 $4.73 Billion
Q2 2024 May 14, 2025	SELL	$262.75 - $319.31 $51.8 Million - $63 Million	-197,144 Reduced 1.35%	14,362,478 $4.49 Billion
Q2 2024 Oct 17, 2024	BUY	$262.75 - $319.31 $103 Million - $125 Million	390,515 Added 2.79%	14,362,478 $4.49 Billion
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $103 Million - $125 Million	390,515 Added 2.79%	14,362,478 $4.49 Billion
Q1 2024 Oct 17, 2024	SELL	$268.87 - $324.56 $105 Million - $127 Million	-390,515 Reduced 2.72%	13,971,963 $3.97 Billion
Q1 2024 Aug 16, 2024	SELL	$268.87 - $324.56 $124 Million - $150 Million	-462,099 Reduced 3.2%	13,971,963 $3.97 Billion
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $124 Million - $150 Million	-462,099 Reduced 3.2%	13,971,963 $3.97 Billion
Q4 2023 Aug 16, 2024	BUY	$255.7 - $288.46 $18.3 Million - $20.6 Million	71,584 Added 0.5%	14,434,062 $4.16 Billion
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $303 Million - $342 Million	1,186,089 Added 8.95%	14,434,062 $4.16 Billion
Q3 2023 Nov 15, 2023	SELL	$218.65 - $271.46 $77 Million - $95.6 Million	-352,016 Reduced 2.59%	13,247,973 $3.56 Billion
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $169 Million - $200 Million	789,192 Added 6.16%	13,599,989 $3.02 Billion
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $111 Million - $135 Million	-490,568 Reduced 3.69%	12,810,797 $3.1 Billion
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $349 Million - $443 Million	1,523,665 Added 12.94%	13,301,365 $3.49 Billion
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $526 Million - $593 Million	-2,342,274 Reduced 16.59%	11,777,700 $2.65 Billion
Q2 2022 Oct 27, 2022	SELL	$230.71 - $256.74 $71.1 Million - $79.1 Million	-308,145 Reduced 2.14%	14,119,974 $3.44 Billion
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $71.1 Million - $79.1 Million	-308,145 Reduced 2.14%	14,119,974 $3.44 Billion
Q1 2022 Oct 27, 2022	BUY	$219.27 - $242.57 $67.6 Million - $74.7 Million	308,145 Added 2.18%	14,428,119 $3.49 Billion
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $1.05 Billion - $1.16 Billion	4,767,146 Added 49.34%	14,428,119 $3.49 Billion
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $48.9 Million - $56 Million	-245,872 Reduced 2.48%	9,660,973 $2.17 Billion
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $2.1 Billion - $2.46 Billion	9,906,845 New	9,906,845 $2.11 Billion

Others Institutions Holding AMGN

# of Institutions

3,310

Shares Held

429M

Call Options Held

8.06M

Put Options Held

7.7M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $157B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account